<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Prev Med</journal-id><journal-id journal-id-type="iso-abbrev">Am J Prev Med</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>American journal of preventive medicine</journal-title></journal-title-group><issn pub-type="ppub">0749-3797</issn><issn pub-type="epub">1873-2607</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10084723</article-id><article-id pub-id-type="pmcid-ver">PMC10084723.1</article-id><article-id pub-id-type="pmcaid">10084723</article-id><article-id pub-id-type="pmcaiid">10084723</article-id><article-id pub-id-type="manuscript-id">NIHMS1888449</article-id><article-id pub-id-type="pmid">36335079</article-id><article-id pub-id-type="doi">10.1016/j.amepre.2022.09.008</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1888449</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1888449</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Leveling the Playing Field: Mailing Pharmacotherapy to Medicaid Members Who Smoke</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>McQueen</surname><given-names initials="A">Amy</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wartts</surname><given-names initials="JG">Jordyn G.</given-names></name><degrees>MPH</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garg</surname><given-names initials="R">Rachel</given-names></name><degrees>MPH</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carpenter</surname><given-names initials="K">Kelly</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kreuter</surname><given-names initials="MW">Matthew W.</given-names></name><degrees>PhD, MPH</degrees><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1.</label>Department of Medicine, Washington University School of Medicine, St. Louis, Missouri;</aff><aff id="A2"><label>2.</label>Health Communication Research Laboratory, Washington University Brown School, St. Louis, Missouri;</aff><aff id="A3"><label>3.</label>Center for Wellbeing Research, OptumHealth, Seattle, Washington</aff><author-notes><corresp id="CR1">Address correspondence to: Amy McQueen, PhD, Washington University, 4523 Clayton Ave., Campus Box 8005, St. Louis MO 63110. <email>amcqueen@wustl.edu</email>.</corresp><fn fn-type="COI-statement" id="FN2"><p id="P39">All authors have no financial conflicts of interest to report.</p></fn></author-notes><pub-date pub-type="ppub"><month>2</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>03</day><month>11</month><year>2022</year></pub-date><volume>64</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">433109</issue-id><fpage>227</fpage><lpage>234</lpage><pub-history><event event-type="nihms-submitted"><date><day>05</day><month>04</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>02</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>02</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 05:25:25.783"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1888449.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction:</title><p id="P1">Smoking rates differ by insurance type; rates are often double for Medicaid and uninsured compared with Medicare or private insurance. State-funded tobacco quitlines&#8217; provision of free nicotine replacement therapy (NRT) varies. In some states, Medicaid beneficiaries must obtain NRT from a physician, whereas others get NRT mailed to them.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">This secondary analysis examined differences in the source and use of cessation treatment by insurance type, and their effects on cessation. The parent trial excluded people who were pregnant, had private insurance, or were not ready to quit. From June 1, 2017 to November 15, 2020, 1,944 low-income people who smoke daily completed a baseline survey and were enrolled in a quitline program; 1,380 (71%) completed 3-month follow up. Analyses were completed in August 2022. Participants were classified as Medicaid/Dual (55%), Medicare/VA (14%) or uninsured (31%). Nine months into the trial, due to a system error, the quitline provided NRT to all study participants regardless of insurance type.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Pre-error vs post-error: Medicaid participants reported lower NRT receipt (3.2% vs 50.8%) and use (32.4% vs 52.6%). Odds of quitting (7-day point prevalence) by 3 months increased for people who smoke who completed more quitline calls and used any (36% quit) vs no (20% quit) pharmacotherapy, but quitting did not differ by insurance classifications (27%&#8210; 29%). Getting and using NRT from the quitline produced the highest quit rates (38%).</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">Results illustrate the benefit of receiving NRT from the quitline on cessation. Mailing NRT to all people who smoke should be standard practice to reduce smoking disparities.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>